ReTuBi: Towards Outstanding Research and Training in Tumour Biology
Please LIKE our video! Help us spread our project worldwide!
Cancer is a worldwide leading cause of death and is a major public health issue. It has also an impact in economic growth, through premature death and disability arising from cancer. Moreover, it has been estimated that 1 in 2 people in the European Union will get cancer in their lifetime. The Instituto de Medicina Molecular – João Lobo Antunes (iMM) aims to fight this destructive disease by reinforcing its capacity for outstanding pre-clinical and translation research. The overall goal is to strengthen iMM in REsearch in TUmour BIology through the establishment of a network of interactions between iMM in Portugal, Institut Curie in France and the German Cancer Research Centre (DKFZ) in Germany.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 692322.